Skip to main content
Equibles

MetLife Investment Management, LLC

Position in ANIK — Anika Therapeutics, Inc.

CIK 1529735 Whippany, NJ
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$104,194
+$925 QoQ
Shares Held
7,122
0.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 134 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $106,800,407 across 37 Drug Manufacturers - Specialty & Generic names. ANIK ranks #33 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALKS
Alkermes plc.
 512,924 $26,877,217
2 UTHR
UNITED THERAPEUTICS Corp
 20,421 $11,064,710
3 NBIX
Neurocrine Biosciences Inc
 51,732 $8,718,911
4 ZTS
Zoetis Inc.
 108,947 $7,828,931
5 HIMS
Hims & Hers Health, Inc.
 224,462 $7,782,097
6 LNTH
Lantheus Holdings, Inc.
 68,281 $7,575,094
7 ELAN
Elanco Animal Health Inc
 240,384 $5,915,850
8 VTRS
Viatris Inc
 266,382 $4,230,146

All Filings in ANIK

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $104,194 7,122
2026-03-31 $103,269 7,122
2025-03-31 $127,995 8,516
2024-12-31 $140,173 8,516
2024-09-30 $210,345 8,516
2024-06-30 $215,710 8,516
2024-03-31 $195,199 7,685
2023-12-31 $174,142 7,685
2023-09-30 $143,171 7,685
2023-06-30 $199,656 7,685
2023-03-31 $220,713 7,685
2022-12-31 $227,476 7,685
2022-09-30 $203,014 8,530
2022-06-30 $190,389 8,530
2022-03-31 $214,188 8,530
2021-12-31 $177,286 4,948
2021-09-30 $301,622 7,087
2021-06-30 $306,796 7,087
2021-03-31 $289,078 7,087
2020-12-31 $320,757 7,087
2020-09-30 $250,808 7,087
2020-06-30 $267,392 7,087
2020-03-31 $204,885 7,087